Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 11Cancer Pain 11Pain 9Pain, Postoperative 5Agnosia 5Colorectal Neoplasms 3Colonic Neoplasms 3Neoplastic Cells, Circulating 2Neoplasm Metastasis 2Mucositis 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Inflammation 2Head and Neck Neoplasms 2Chronic Pain 2Breakthrough Pain 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Supratentorial Neoplasms 1Stomach Neoplasms 1Signs and Symptoms 1Sezary Syndrome 1Reperfusion Injury 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Fentanyl 5Morphine 2Urinary Catheterization 1Ultracet 1Patient Positioning 1Methadone 1Gastrostomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breakthrough Pain × Morphine × Clear all
NCT05037539 2022-08-31

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Department of Medical Services Ministry of Public Health of Thailand

Phase 1/2 Completed
20 enrolled

Breakthrough Pain

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed
20 enrolled
Head & Neck

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡